Sanofi-Regeneron
Sanofi-Regeneron
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events | Any Advanced Solid Tumors | Not yet recruiting | Phase 2 | 2026-09-23 | NCT07836101 |